Stanford Medicine is leading the biomedical revolution in precision health by leveraging our iconic place in Silicon Valley and the university’s innovation and excellence across disciplines.
Starton Therapeutics is a clinical-stage biotechnology company focused on improving standard-of-care therapies with our proprietary platform of continuous delivery technology systems to deliver superi
...
Stealth BioTherapeutics is a commercial stage biotech company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Forzi
...
Stingray is a clinical stage biotech company that has developed potent and selective small molecule inhibitors of ENPP1, Ectonucleotide Pyrophosphatase / Phosphodiesterase1.
Founded in 2021, SymBiosis Capital Management is a venture capital firm based in Bentonville, Arkansas. The firm prefers to invest in the biotherapeutics sector.
SyneuRx Neuroscience is developing new-generation treatment for depression and dementia by targeting the N-methyl-D-aspartate receptor (NMDAR) in the glutamate system—the most abundant system in the b
...
Syno Capital is a global investment firm focused on developing breakthrough innovations to meet our healthcare challenges. We strive to work with the greatest minds no matter where they are to tackle
...
At T.Rx Capital, we partner with founders reimagining what’s possible in healthcare. With decades of experience building and scaling healthcare companies, we bring more than capital — we bring convict
...